We believe hypochlorous acid (HOCl) has the potential to fundamentally transform the way the world approaches disease prevention and infection control. Today’s pathogen defense and transmission (PDT) methods rely on products that are highly toxic, corrosive, and often ineffective in real-world use. This broken approach compromises human health, damages environments, and creates a dangerous false sense of protection. Large-scale health events have made this unmistakably clear—leaving institutions, communities, and families vulnerable because the tools we depend on simply do not work as intended. HOCl changes that.

HOCl is a molecule the human body naturally produces to fight infection. When stabilized and deployed properly, it offers a radically different solution—one that is effective against pathogens while remaining safe for people, animals, and the environments they inhabit. This makes HOCl uniquely suited for use across hospitals, public health and pandemic response, agriculture, commercial facilities, and everyday home environments. Beyond prevention, HOCl plays a powerful role in healing—supporting wound and burn care by reducing infection risk, accelerating healing, and alleviating suffering without the toxicity or tissue damage associated with conventional treatments. We also recognize that disease prevention does not stop with humans. Animals are equally vulnerable to infection, and HOCl provides a safer, more effective way to help prevent the spread of diseases like kennel cough and parvovirus, while supporting the treatment of animal wounds that are often difficult to manage. At its core, the problem we set out to solve is simple but urgent: how do we protect life—human and animal—without causing harm in the process? HOCl is our answer.